Actas Dermosifiliogr
http://www.ncbi.nlm.nih.gov/pubmed/25398489
105 Suppl 1:21-33
https://connects.catalyst.harvard.edu/Profiles/profile/35872915
IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
Actas Dermosifiliogr
http://www.ncbi.nlm.nih.gov/pubmed/25398489
105 Suppl 1:21-33
https://connects.catalyst.harvard.edu/Profiles/profile/35872915